Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel grant 2020, Switzerland 20200206

Reference number
Coordinator NEXTCELL PHARMA AB
Funding from Vinnova SEK 15 000
Project duration January 2020 - February 2020
Status Completed

Important results from the project

** Denna text är maskinöversatt ** NextCells participated in Swiss Nordic Bio to present impact data with the company´s stem cell treatment ProTrans, for international and capital-rich organizations.

Expected long term effects

** Denna text är maskinöversatt ** An initial contact was established at the meeting, which is now being followed up remotely.

Approach and implementation

** Denna text är maskinöversatt ** Classic partnering and investor meeting.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 6 March 2020

Reference number 2020-00020